- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neurogenic Bladder in United Kingdom
Total 1559 results
-
Aura BiosciencesRecruitingMuscle-Invasive Bladder Carcinoma | Non-muscle-invasive Bladder CancerUnited States
-
University of KentuckyBayerTerminated
-
Cedars-Sinai Medical CenterRecruitingOveractive BladderUnited States
-
University of Michigan Rogel Cancer CenterCompleted
-
Mary Babb Randolph Cancer Center at West Virginia...Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Urothelial Carcinoma | Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant | Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant | Infiltrating Bladder Urothelial Carcinoma With Glandular Differentiation | Infiltrating Bladder Urothelial Carcinoma With Squamous... and other conditionsUnited States
-
Case Comprehensive Cancer CenterPfizerTerminatedRecurrent Bladder Cancer | Transitional Cell Carcinoma of the BladderUnited States
-
University of California, IrvineCompletedOveractive Bladder | Urgency-FrequencyUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedBladder CarcinomaUnited States
-
Vanderbilt UniversityUniversity of OklahomaCompletedBladder CancerUnited States
-
Anthra PharmaceuticalsCompleted
-
David LatiniCompleted
-
State University of New York at BuffaloAstellas Pharma IncWithdrawnUrinary Frequency/Urgency | Bladder Pain Syndrome | Bladder IrritableUnited States
-
BayerCompleted
-
Daniel George, MDAstraZenecaWithdrawn
-
University of Michigan Rogel Cancer CenterCelgene CorporationTerminatedBladder Cancer | Urothelial CancerUnited States
-
Washington University School of MedicineCompletedOveractive BladderUnited States
-
Loma Linda UniversityWithdrawnOveractive BladderUnited States
-
AllerganCompleted
-
Weill Medical College of Cornell UniversityCompletedOveractive BladderUnited States
-
Johns Hopkins UniversityWithdrawn
-
Cancer Research UKUnknownLymphoma | Kidney Cancer | Pancreatic Cancer | Esophageal Cancer | Brain and Central Nervous System Tumors | Bladder Cancer | Intraocular Melanoma | Melanoma (Skin) | Transitional Cell Cancer of the Renal Pelvis and UreterUnited Kingdom
-
Vaxiion TherapeuticsCompletedUrothelial Carcinoma of the Urinary BladderUnited States
-
Cedars-Sinai Medical CenterTerminated
-
White River Junction Veterans Affairs Medical CenterMedical University of South Carolina; National Cancer Institute (NCI); University...RecruitingNon-muscle-invasive Bladder CancerUnited States
-
Ikena OncologyBristol-Myers SquibbCompletedNeoplasms | Neoplasm Metastasis | Solid Tumor | Metastatic Cancer | Bladder Cancer | Advanced Solid Tumor | Advanced Cancer | Urothelial Carcinoma Bladder | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Solid Tumor, Adult | Bladder Disease | Solid Carcinoma | Neoplasm Malignant | Neoplasm, Bladder | Locally Advanced... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedBladder CancerUnited States
-
AstraZenecaCompletedBladder Cancer | Urethra Cancer | Ureter Cancer | Renal Pelvis Cancer | Transitional Cell Bladder CancerUnited States, Spain, United Kingdom, Germany, Canada
-
University of ArizonaRecruiting
-
The Cleveland ClinicCompletedProphylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate AdenocarcinomaProstate Cancer | Post-Brachytherapy Bladder Outlet ObstructionUnited States
-
Frank TuBerlex FoundationTerminated
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnInfiltrating Bladder Urothelial Carcinoma | Stage II Bladder Urothelial Carcinoma | Stage IV Bladder Urothelial Carcinoma | Stage III Bladder Urothelial CarcinomaUnited States
-
Applied Spectral Imaging Ltd.CompletedBladder CancersUnited States
-
Southern Illinois UniversityMerck Sharp & Dohme LLCActive, not recruiting
-
Loyola UniversityKimberly-Clark CorporationCompletedOveractive Bladder | Nocturia | IncontinenceUnited States
-
AllerganCompletedOveractive Bladder | Pharmacokinetics | ElderlyUnited States
-
Dana-Farber Cancer InstituteEMD Serono; National Comprehensive Cancer NetworkRecruitingBladder Cancer | Urothelial Carcinoma | Metastatic Bladder Cancer | Unresectable Bladder CarcinomaUnited States
-
Omar MianGilead Sciences; Varian IncNot yet recruitingMuscle-Invasive Bladder Carcinoma | Localized Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedBladder CancerUnited States
-
IntracelCompletedBladder CancerUnited States
-
OnxeoCompletedOvarian Cancer | Fallopian Tube Cancer | Bladder Cancer | Epithelial Ovarian CancerUnited States, Denmark, United Kingdom
-
Urovant Sciences GmbHIon Channel InnovationsCompletedOveractive BladderUnited States
-
University of Alabama at BirminghamCompletedOveractive Bladder | Lower Urinary Tract SymptomsUnited States
-
William Beaumont HospitalsTerminatedOveractive Bladder | Urinary Bladder, Overactive | Urinary Incontinence | Overactive Bladder Syndrome | Urinary Urgency | Urinary Frequency/UrgencyUnited States
-
NanOlogy, LLCUS Biotest, Inc.CompletedUrologic Neoplasms | Urogenital Neoplasms | Urinary Bladder Cancer | Bladder Cancer | Urothelial Carcinoma | Urologic Cancer | Urinary Bladder Neoplasm | Cancer of the Bladder | Malignant Tumor of the Urinary BladderUnited States
-
University of MiamiNational Cancer Institute (NCI)CompletedBladder Cancer Requiring CystectomyUnited States
-
Bavarian NordicCompletedBladder CancerUnited States
-
CG Oncology, Inc.Merck Sharp & Dohme LLCActive, not recruitingNon Muscle Invasive Bladder CancerUnited States, Korea, Republic of
-
The University of Texas Health Science Center at...WithdrawnSecondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder CancerBladder CancerUnited States